SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Using mixed treatment comparisons and meta‐regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis
3 references·16 citing·48 second hop
Using mixed treatment comparisons and meta‐regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis (2006)Using mixed treatment comparisons and met…Combination of direct and indirect evidence in mixed treatment comparisons (2004)Combination of direct and ind…Network meta‐analysis for indirect treatment comparisons (2002)Network meta‐analysis for ind…How should meta‐regression analyses be undertaken and interpreted? (2002)How should meta‐regression an…Simulation and Matching-Based Approaches for Indirect Comparison of Treatments (2015)Simulation and Matching-Based…A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons (2015)A Bayesian missing data frame…Balancing benefit and risk of medicines: a systematic review and classification of available methodologies (2014)Balancing benefit and risk of…Incorporating data from various trial designs into a mixed treatment comparison model (2013)Incorporating data from vario…A Bayesian network meta-analysis for binary outcome: how to do it (2013)A Bayesian network meta-analy…Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons (2012)Simulation evaluation of stat…Mixed treatment comparisons using aggregate and individual participant level data (2012)Mixed treatment comparisons u…Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes (2012)Meta-regression models to add…Linear inference for mixed treatment comparison meta‐analysis: a two‐stage approach (2012)Linear inference for mixed tr…Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials (2012)Combining individual patient …Multiple treatment comparison meta-analyses: a step forward into complexity (2011)Multiple treatment comparison…Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency (2010)Mixed treatment comparison an…Evaluating novel agent effects in multiple‐treatments meta‐regression (2010)Evaluating novel agent effect…Biologic drugs for rheumatoid arthritis in the medicare program: A cost‐effectiveness analysis (2008)Biologic drugs for rheumatoid…Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry (2007)Modelling the cost effectiven…Meta‐analysis of mixed treatment comparisons at multiple follow‐up times (2007)Meta‐analysis of mixed treatm…Meta-analysis in clinical trials (1986)Checking consistency in mixed treatment comparison meta‐analysis (2010)Graphical Tools for Network Meta-Analysis in STATA (2013)Network meta-analysis of randomized clinical trials: Reporting the proper summaries (2013)ANOVA model for network meta-analysis of diagnostic test accuracy data (2016)Theory and practice of Bayesian and frequentist frameworks for network meta-analysis (2022)Measurement of patient outcome in arthritis (1980)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical Outcomes (2013)The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis (2013)The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review (2015)10.1007/978-1-4899-4485-6 (2000)ROBIS: A new tool to assess risk of bias in systematic reviews was developed (2015)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Modeling Valuations for EuroQol Health States (1997)Using the health assessment questionnaire to estimate preference‐based single indices in patients with rheumatoid arthritis (2007)Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis (2010)Using surveys to value public goods: the contingent valuation method (1989)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Stated choice methods analysis and applications (2000)Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective (2016)Recommendations for benefit–risk assessment methodologies and visual representations (2016)Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review (2018)The Handbook of Research Synthesis. (1995)Cochrane Handbook for Systematic Reviews of Interventions (2008)The evolution of a new publication type: Steps and challenges of producing overviews of reviews (2010)Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks (2014)Risk of bias in overviews of reviews: a scoping review of methodological guidance and four‐item checklist (2017)Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs (2000)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer (2014)Research Techniques Made Simple: Network Meta-Analysis (2018)Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making (2020)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review (2013)Evidence Synthesis for Decision Making 7 (2013)Twenty years of network meta‐analysis: Continuing controversies and recent developments (2024)Statistical Methods for Meta-Analysis. (1986)Statistical Methods for Meta-Analysis (1988)Bias in meta-analysis detected by a simple, graphical test (1997)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)Outlier and influence diagnostics for meta-analysis (2010)Interpretation of random effects meta-analyses (2011)Consistency and inconsistency in network meta‐analysis: model estimation using multivariate meta‐regression (2012)Evidence Synthesis for Decision Making 2 (2012)Evaluating the Quality of Evidence from a Network Meta-Analysis (2014)
this work references cited by second hop

References

  • 2002How should meta‐regression analyses be undertaken and interpreted?3,021 cited
  • 2004Combination of direct and indirect evidence in mixed treatment comparisons2,168 cited
  • 2002Network meta‐analysis for indirect treatment comparisons1,204 cited

Cited by

  • 2008Biologic drugs for rheumatoid arthritis in the medicare program: A cost‐effectiveness analysis138 cited
  • 2010Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency135 cited
  • 2015A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons132 cited
  • 2014Balancing benefit and risk of medicines: a systematic review and classification of available methodologies130 cited
  • 2007Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry122 cited
  • 2013Incorporating data from various trial designs into a mixed treatment comparison model121 cited
  • 2007Meta‐analysis of mixed treatment comparisons at multiple follow‐up times117 cited
  • 2012Mixed treatment comparisons using aggregate and individual participant level data116 cited
  • 2010Evaluating novel agent effects in multiple‐treatments meta‐regression111 cited
  • 2015Simulation and Matching-Based Approaches for Indirect Comparison of Treatments

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

110 cited
  • 2013A Bayesian network meta-analysis for binary outcome: how to do it98 cited
  • 2012Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials95 cited
  • 2011Multiple treatment comparison meta-analyses: a step forward into complexity92 cited
  • 2012Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes92 cited
  • 2012Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons92 cited
  • 2012Linear inference for mixed treatment comparison meta‐analysis: a two‐stage approach85 cited